Inhibition of Oral Tumorigenesis by Antitumor B

This research study is being conducted to determine the effectiveness of Antitumor B (ATB), a botanical agent composed of six Chinese herbs, to slow down tumor growth. ATB is still experimental, meaning it is not approved by the U.S. Food and Drug Administration (FDA). We do not know all the ways that this compound may affect people